Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1Gynecologic 1

Conditions

Neoplasms 1Lymphoma, Follicular 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 744Bevacizumab 716Cisplatin 708Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 338Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Diet, Ketogenic × Clear all
NCT04750941 2025-03-04

Study of Copanlisib and Ketogenic Diet

Columbia University

Phase 2 Terminated
1 enrolled 9 charts
GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms

NCT01716468 2016-05-09

Ketogenic Diet in Advanced Cancer

VA Pittsburgh Healthcare System

Phase NA Completed
17 enrolled 5 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡